About the Authors
University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
University of Vermont, Burlington, Vermont, United States of America
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Saint-Pierre Hospital, Brussels, Belgium
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
University Hospital, Zurich, Switzerland
University of Copenhagen, Copenhagen, Denmark
University of Minnesota, Minneapolis, Minnesota, United States of America
Virginia Commonwealth University, Richmond, Virginia, United States of America
Medical Research Council Clinical Trials Unit, London, United Kingdom
Bruno Ledergerber reported travel grants, grants or honoraria from Abbott, Aventis, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck Sharp & Dohme, Roche and Tibotec. Jens Lundgren reported honoraria and research grants from Boehringer-Ingelheim, Roche, Abbott, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Tibotec, Pfizer, and Gilead. Russell Tracy reported the following activities: (1) Wake Forest University Pepper Center on Aging—External Advisory Board; (2) Johns Hopkins University Pepper Center on Aging—External Advisory Board; (3) University of Florida Pepper Center on Aging—External Advisory Board; (4) Haematologic Technologies—owner; thrombosis and fibrinolysis biochemical reagents and blood collection tubes; contract research in this area; and (5) Ashcraft & Gerel Attorneys at Law—consulting on mechanisms in inflammation, atherosclerosis and thrombosis.
All of the authors provided input to drafts of the manuscript. LHK, RT, and JDN are responsible for the design of the biomarker study. RT's laboratory carried out the analyses of the specimens. JDN was a co-chair of the SMART study. JDN and JN carried out data analyses for the paper.